Developing strategic approaches for overcoming the formidable challenge of multidrug resistance in cancer treatment requires a deep comprehension of the complicated interplay between drug sequestration, lysosomal complexity, and MDR1 gene regulation. This evidence concerns the gene ABCB1 and cancer.